NCT05206578

Study to Evaluate the Efficacy and Safety in Patients With Primary Hypercholesterolemia

To Evaluate the Efficacy and Safety of Combination Therapy of AGT and AGZ Versus Monotherapy of AGT in Patients With Primary Hypercholesterolemia

• Status: Unknown
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 264 (estimated)
• Sponsor: Ahn-Gook Pharmaceuticals Co.,Ltd · Industry
• Sex: All
• Age: 19 Years – 79 Years
• Healthy volunteers: Not accepted

Summary

To Evaluate the Efficacy and Safety of Combination Therapy of AGT and AGZ Versus Monotherapy of AGT in Patients With Primary Hypercholesterolemia.

Detailed description

A Multi-center, Randomized, Double-blinded, Active-controlled, Factorial Design Phase 3 Clinical Trial

Conditions

• Primary Hypercholesterolemia

Interventions

Type	Name	Description
DRUG	AGT2, AGZ	Tablet, q.d.
DRUG	AGT2	Tablet, q.d.
DRUG	AGT4, AGZ	Tablet, q.d.
DRUG	AGT4	Tablet, q.d.

Timeline

• Start date: 2020-12-08
• Primary completion: 2022-07-07
• Completion: 2022-09-08
• First posted: 2022-01-25
• Last updated: 2022-01-25

Locations

1 site across 1 country: South Korea